Nick Slavin is the Co-Founder and CEO of Fuzionaire, which is commercializing the breakthrough in “green chemistry” featured in the short film Element 19, based on a revolutionary new catalyst discovered in a Nobel Laureate's lab at Caltech; and Fuzionaire Diagnostics, which is developing customized molecular imaging agents for the non-invasive detection and localization of cancer and other diseases.
Nick is also the Founder and Chairman of the Slavin Family Foundation, whose Slavin Fellowship offers support, mentorship, and a scholarship to undergraduate and graduate students pursuing potentially world-changing entrepreneurial projects.
Nick founded his first company as an 18-year-old senior at Yale, and has since founded, advised, and invested in a variety of startups in energy, medicine, education, blockchain, and virtual and augmented reality. He is also the Founder and Managing Partner of EES Ventures, a seed-stage venture capital firm.
For seven years, he was a corporate attorney at Norton Rose Fulbright and Skadden, Arps, Slate, Meagher & Flom LLP, which has been ranked the #1 corporate law firm by Corporate Board Member magazine for 17 consecutive years.
He holds a BA, magna cum laude, Phi Beta Kappa, from Yale, and a JD from Harvard Law School.